# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 111-120 of 626 results.
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI)
Status: Recruiting
Last Changed: May 15, 2019
First Received: Feb 15, 2019
Disease(s): Ovary Neoplasms, Ovarian Cancer, Ovarian Carcinoma
Intervention(s): HIPEC
Locations: Centre François Baclesse, Caen, France
Centre Jean Perrin, Clermont-Ferrand, France
Centre Oscar Lambret, Lille, France
ICM-Val d'Aurelle, Montpellier, France
Centre Hospitalier Lyon Sud, Pierre-Bénite, France
... and 4 other locations.
HE4 as a Relapse Biomarker in Ovarian Cancers
Status: Recruiting
Last Changed: Apr 03, 2019
First Received: Nov 03, 2015
Disease(s): Ovarian Carcinoma
Intervention(s): Experimental arm
Locations: BENGRINE-LEVEVRE Leïla, Dijon, Centre Georges François Leclerc, France
AZEMAR Marc, Strasbourg, Centre Paul Strauss, France
LONGO Raphaelle, Metz, CHU Metz Thionville, France
KURTZ Jean-Emmanuel, Strasbourg, Hôpital Civil, France
KALBACHER Elsa, Besançon, Hôpital Jean Minjoz, France
... and 3 other locations.
Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer
Status: Recruiting
Last Changed: Nov 15, 2019
First Received: Aug 15, 2017
Disease(s): Ovarian Cancer
Intervention(s): ARM A Durvalumab/chemotherapy association, ARM B Durvalumab/Tremelimumab/chemotherapy association
Locations: Hôpital Henri Duffaut, Avignon, France
Institut Ste Catherine, Avignon, France
Institut Bergonié, Bordeaux, France
Centre Oscar Lambret, Lille, France
ICM Val d'Aurelle, Montpellier, France
... and 10 other locations.
Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer
Status: Recruiting
Last Changed: Jan 15, 2019
First Received: Oct 02, 2015
Disease(s): Ovarian Cancer, Primary Peritoneal Cancer
Intervention(s): Cytoreductive surgery, IPEC with Cisplatin (75mg/m²), IPEC with Cisplatin (100mg/m²), Hypertherm IntraPEritoneal Chemotherapy with Cisplatin (75mg/m²), HIPEC with Cisplatin (100mg/m²)
Locations: UZ Ghent, Ghent, East-Flanders, Belgium
An Observational Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
Status: Recruiting
Last Changed: Feb 05, 2020
First Received: Aug 30, 2013
Disease(s): Ovarian Cancer, Peritoneal Neoplasms
Locations: Sir Gangaram Hospital, New Delhi, Delhi, India
Shalby Hospital Limited, Ahmedabad, Gujarat, India
Manipal Hospital; Department of Oncology, Bangalore, Karnataka, India
HCG NMR Cancer Centre, Hubli, Karnataka, India
HCG NCHRI Cancer Center, Nagpur, Maharashtra, India
... and 18 other locations.
PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer
Status: Recruiting
Last Changed: May 29, 2019
First Received: May 29, 2019
Disease(s): Malignant Ovarian Neoplasm, Ovarian Carcinoma
Intervention(s): Dynamic Enhanced CT, Magnetic Resonance Imaging, Positron Emission Tomography
Locations: M D Anderson Cancer Center, Houston, Texas, United States
NIraparib and Quality Of LifE is a Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib.
Status: Recruiting
Last Changed: Feb 12, 2020
First Received: Nov 23, 2018
Disease(s): Ovarian Cancer
Intervention(s): Niraparib
Locations: Institut Sainte-Catherine, Avignon, France
Centre Hospitalier de la Côte Basque, Bayonne, France
CHRU Jean Minjoz, Besançon, France
Clinique Tivoli, Bordeaux, France
Institut Bergonié, Bordeaux, France
... and 30 other locations.
HIPEC in the Treatment of Stage IIc-IV Epithelial Ovarian Cancer After CRS (HIPECOC)
Status: Not yet recruiting
Last Changed: Feb 21, 2020
First Received: Feb 21, 2020
Disease(s): Ovarian Cancer, Hyperthermic Intraperitoneal Chemotherapy
Intervention(s): Hyperthermic Intraperitoneal Chemotherapy
Use of Regorafenib in Recurrent Epithelial Ovarian Cancer
Status: Recruiting
Last Changed: Sep 17, 2018
First Received: Apr 13, 2016
Disease(s): Ovarian Neoplasms
Intervention(s): Regorafenib
Locations: National Cancer Centre Singapore, Singapore, Singapore
Efficacy and Safety of Apatinib As Third Line Therapy in Patients With Advanced Ovarian Cancer
Status: Recruiting
Last Changed: Aug 28, 2017
First Received: Aug 25, 2017
Disease(s): Angiogenesis Inhibitors,Ovarian Neoplasms
Intervention(s): apatinib, Placebos
Locations: Sichuan Cancer Hospital, Chendu, Sichuan, China